Targeting Glutamate to Treat PTSD: A Double-blind, Randomized, Placebo-controlled Trial
Abdallah Chadi, MD
Seminar date: 6/7/2022
Description: The presentation will summarize the rationale behind targeting glutamate to treat PTSD. Then, present the study design and results of a placebo-controlled, parallel arms, randomized clinical trial investigating the effects of standard and low dose ketamine on PTSD symptoms in Veterans and active duty military.